XML 42 R28.htm IDEA: XBRL DOCUMENT
v3.25.1

STOCKHOLDERS DEFICIENCY (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2025
STOCKHOLDERS DEFICIENCY |
Equity Distribution Agreement |
|  | Nine Months Ended March 31, 2024 |  |  | Cumulative from inception |
|  | Shares |  |  | Proceeds |  |  | Shares |  |  | Proceeds |
Gross proceeds |  |  | 217,027 |  |  | $ | 547,803 |  |  |  | 721,061 |  |  | $ | 1,744,542 |
Fees |  |  | - |  |  |  | (16,434 | ) |  |  | - |  |  |  | (52,336 | )
Expenses |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (126,800 | )
Net proceeds |  |  | 217,027 |  |  | $ | 531,369 |  |  |  | 721,061 |  |  | $ | 1,565,406 |
Outstanding Stock Purchase Warrants |
|  | Shares of Common |  |  | Exercise Price per |  |  | Latest Expiration |
Description |  | Stock |  |  | Share |  |  | Date |
May 2022 Warrants |  |  | 66,666 |  |  | $ | 12.50 |  |  | May 11, 2026 |
October 2022 Placement Agent Warrants |  |  | 90,909 |  |  | $ | 6.88 |  |  | October 31, 2027 |
October 2023 Placement Agent Warrants |  |  | 117,925 |  |  | $ | 2.65 |  |  | October 20, 2028 |
January 2024 Private Warrants |  |  | 1,831,503 |  |  | $ | 5.46 |  |  | February 1, 2028 |
January 2024 Placement Agent Warrants |  |  | 91,575 |  |  | $ | 6.83 |  |  | February 1, 2028 |
June 2024 Series B Warrants |  |  | 1,885,632 |  |  | $ | 1.88 |  |  | June24,2029* |
December 2024 Series C Warrants |  |  | 3,907,679 |  |  | $ | 0.88 |  |  | December 17, 2029 |
December 2024 Series D Warrants |  |  | 1,953,839 |  |  | $ | 0.88 |  |  | ** |
February 2025 Series E Warrants |  |  | 4,688,000 |  |  | $ | 1.00 |  |  | August 12, 2030 |
* 1,624,201 shares expire on the five year anniversary following stockholder approval of the warrant issuance and the balance expire on June 24, 2029. |
** 1,953,839 shares expire on the five year anniversary following stockholder approval of the warrant issuance. |  |  |  |
Option activity |
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Term in Years |  |  | Aggregate Intrinsic Value |
Outstanding - June 30, 2024 |  |  | 2,263,440 |  |  | $ | 6.11 |  |  |  | 8.2 |  |  |  |
Granted |  |  | - |  |  |  | - |  |  |  |  |  |  |  |
Forfeited |  |  | - |  |  |  | - |  |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  |
Expired |  |  | (14,338 | ) |  |  | 4.50 |  |  |  |  |  |  |  |
Outstanding - March 31, 2025 |  |  | 2,249,102 |  |  | $ | 6.12 |  |  |  | 7.5 |  |  | $ | - |
Exercisable at March 31, 2025 |  |  | 937,894 |  |  | $ | 10.77 |  |  |  | 5.9 |  |  | $ | - |
Expected to vest at March 31, 2025 |  |  | 1,311,208 |  |  | $ | 2.80 |  |  |  | 8.6 |  |  | $ | - |
Restricted Stock Units |
Outstanding at June 30, 2024 |  |  | 1,374,980 |
Granted |  |  | - |
Forfeited |  |  | - |
Vested |  |  | (232,941 | )
Expirations |  |  | (2,726 | )
Outstanding at March 31, 2025 |  |  | 1,139,313 |

X
- References No definition available. + Details
Name: | ptn_ScheduleOfEquityDistributionAgreementTableTextBlock
Namespace Prefix: | ptn_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_ScheduleOfStockPurchaseWarrantsTableTextBlock
Namespace Prefix: | ptn_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_StockholdersEquityAndRedeemableConvertiblePreferredStockAbstract
Namespace Prefix: | ptn_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration